Patents by Inventor Mark Niebauer

Mark Niebauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9662029
    Abstract: Systems and methods are provided for evaluating an expected effectiveness of cardiac resynchronization therapy. Electrocardiogram (ECG) data is received as at least one ECG lead from a set of electrodes. A frequency spectrum representing the ECG data is generated via a Fourier transform. At least one predictor value is extracted from the calculated frequency spectrum. A fitness parameter, representing the expected effectiveness of cardiac resynchronization, is determined from at least the extracted predictor value.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: May 30, 2017
    Assignee: The Cleveland Clinic Foundation
    Inventors: Mark Niebauer, Cristian Pasluosta, Niraj Varma
  • Publication number: 20160081573
    Abstract: Systems and methods are provided for evaluating an expected effectiveness of cardiac resynchronization therapy. Electrocardiogram (ECG) data is received as at least one ECG lead from a set of electrodes. A frequency spectrum representing the ECG data is generated via a Fourier transform. At least one predictor value is extracted from the calculated frequency spectrum. A fitness parameter, representing the expected effectiveness of cardiac resynchronization, is determined from at least the extracted predictor value.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 24, 2016
    Inventors: Mark Niebauer, Cristian Pasluosta, Niraj Varma
  • Patent number: 9204815
    Abstract: Systems and methods are provided for evaluating an expected effectiveness of cardiac resynchronization therapy. Electrocardiogram (ECG) data is received as at least one ECG lead from a set of electrodes. A frequency spectrum representing the ECG data is generated via a Fourier transform. At least one predictor value is extracted from the calculated frequency spectrum. A fitness parameter, representing the expected effectiveness of cardiac resynchronization, is determined from at least the extracted predictor value.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: December 8, 2015
    Assignee: The Cleveland Clinic Foundation
    Inventors: Mark Niebauer, Cristian Pasluosta, Niraj Varma
  • Publication number: 20130296726
    Abstract: Systems and methods are provided for evaluating an expected effectiveness of cardiac resynchronization therapy. Electrocardiogram (ECG) data is received as at least one ECG lead from a set of electrodes. A frequency spectrum representing the ECG data is generated via a Fourier transform. At least one predictor value is extracted from the calculated frequency spectrum. A fitness parameter, representing the expected effectiveness of cardiac resynchronization, is determined from at least the extracted predictor value.
    Type: Application
    Filed: May 3, 2013
    Publication date: November 7, 2013
    Applicant: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Mark Niebauer, Cristian Pasluosta, Niraj Varma